Financials

  • Market Capitalization 403.53 M
  • Employee 45
  • Founded 2019
  • CEO N/A
  • Website www.x4pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1CYH8
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
3.68
市销率
35.88

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3044
RCKT
Rocket Pharmaceuticals, Inc. - Common Stock
3.73 USD+0.27%0.00%+19.17%+16.20%409.46 M USD
3046
LRMR
Larimar Therapeutics, Inc. - Common Stock
3.94 USD+3.14%-4.83%+2.87%+6.20%409.30 M USD
3064
EYPT
EyePoint, Inc. - Common Stock
4.58 USD+1.78%-8.76%-62.88%-61.83%394.85 M USD
3068
ENTA
Enanta Pharmaceuticals, Inc. - Common Stock
13.51 USD+1.35%-3.50%+6.38%+49.12%393.48 M USD

新闻